[go: up one dir, main page]

FI803727L - 2,3-indolidionderivat - Google Patents

2,3-indolidionderivat

Info

Publication number
FI803727L
FI803727L FI803727A FI803727A FI803727L FI 803727 L FI803727 L FI 803727L FI 803727 A FI803727 A FI 803727A FI 803727 A FI803727 A FI 803727A FI 803727 L FI803727 L FI 803727L
Authority
FI
Finland
Prior art keywords
indolidionderivat
Prior art date
Application number
FI803727A
Other languages
English (en)
Finnish (fi)
Other versions
FI803727A7 (fi
Inventor
Graham Alwyn Fothergill
John Merwyn Osbond
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI803727A7 publication Critical patent/FI803727A7/fi
Publication of FI803727L publication Critical patent/FI803727L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI803727A 1979-12-07 1980-12-01 2,3-indolidionderivat FI803727L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942324 1979-12-07

Publications (2)

Publication Number Publication Date
FI803727A7 FI803727A7 (fi) 1981-06-08
FI803727L true FI803727L (fi) 1981-06-08

Family

ID=10509706

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803727A FI803727L (fi) 1979-12-07 1980-12-01 2,3-indolidionderivat

Country Status (16)

Country Link
US (1) US4395559A (es)
EP (1) EP0030380A1 (es)
JP (1) JPS5695167A (es)
AR (1) AR226869A1 (es)
AU (1) AU6494680A (es)
DK (1) DK522180A (es)
ES (1) ES497530A0 (es)
FI (1) FI803727L (es)
GR (1) GR72136B (es)
HU (1) HU180620B (es)
IL (1) IL61603A0 (es)
MC (1) MC1357A1 (es)
NO (1) NO803693L (es)
NZ (1) NZ195702A (es)
PT (1) PT72176B (es)
ZA (1) ZA807494B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593106A (en) * 1984-06-04 1986-06-03 Smithkline Beckman Corporation 4-[2-(dialkylamino)ethyl]-7-hydroxyisatins
US4847863A (en) * 1985-10-03 1989-07-11 Watson Bruce W Expandable modular data modem
AR016384A1 (es) 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1778174A (en) * 1926-05-30 1930-10-14 Gen Aniline Works Inc Substituted isatins and process of preparing them
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
CH472404A (de) * 1966-03-04 1969-05-15 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE379196B (es) * 1971-06-24 1975-09-29 Sandoz Ag
US4137331A (en) * 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
US4212804A (en) * 1978-12-04 1980-07-15 Sandoz, Inc. Process for the preparation of optionally substituted 2,3-indolinediones

Also Published As

Publication number Publication date
MC1357A1 (fr) 1981-08-10
EP0030380A1 (de) 1981-06-17
ES8205770A1 (es) 1982-07-01
ZA807494B (en) 1981-11-25
FI803727A7 (fi) 1981-06-08
DK522180A (da) 1981-06-08
HU180620B (en) 1983-03-28
JPS5695167A (en) 1981-08-01
US4395559A (en) 1983-07-26
AU6494680A (en) 1981-06-11
NO803693L (no) 1981-06-09
AR226869A1 (es) 1982-08-31
PT72176A (en) 1981-01-01
NZ195702A (en) 1984-09-28
GR72136B (es) 1983-09-20
PT72176B (en) 1982-07-05
ES497530A0 (es) 1982-07-01
IL61603A0 (en) 1981-01-30

Similar Documents

Publication Publication Date Title
DK537780A (da) 1,8-naphthyridin-derivater
FI792046A7 (fi) Oktahydropyrazolo/3,4-g/kinoliner
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
DK3881A (da) Substituerede 9,10-anthracen-bishydrazoner
FI793663A7 (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
SE7803411L (sv) 2,6-dialkoxibensamider
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
FI803403A7 (fi) Uusia pyridotienotriatsideja.
FI803727L (fi) 2,3-indolidionderivat
NO802888L (no) 2-klor-4,5-disubstituerte-thiazoler
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
NO793494L (no) Sylinderlaas i.
FI792047A7 (fi) Oktahydro-2h-pyrrolo/3,4-g/kinoliner
FI801473A7 (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE883295A (fr) 6,7-secoergolines
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
BE881358A (fr) 25-hydroxycholecalciferol-26,23-lactone
FI803041A7 (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner
DK136379A (da) 4,6-dihalogensteroider
DE2953592A1 (de) 24,24-difluoro-25-hydroxycholecalciferol
DK446582A (da) 24,24-difluor-1alfa,15-dihydro-5,6-transcholecalciferol
NO802405L (no) 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivater
DK430479A (da) 2,6-dihalogenbensylestere
NO812109L (no) Z-profilfoeringsinnretning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO